Trial site
Kameda Medical Center
Kamogawa, 296-8602, JapanNot linked to an institution yet
The trials here
What the 5 trials at this site are about, from their registry records.
- Phase
- Phase 33 trials
- Phase 1/21 trial
- Status
- Active, not recruiting3 trials
- Recruiting2 trials
- Lead sponsor
- Janssen Research & Development, LLC2 trials
- Celgene1 trial
- Juntendo University1 trial
- North East Japan Study Group1 trial
Running trials
Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
NCT07258511· Phase 3· Janssen Research & Development, LLC· Source
Active, not recruiting
A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
NCT05572515· Phase 3· Janssen Research & Development, LLC· Source
Recruiting
Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure
NCT05392764· Phase 3· Juntendo University· Source
Contact: Akira Mizukami
Active, not recruiting
Japanese Idiopathic Interstitial Pneumonias Registry
NCT03041623· North East Japan Study Group· Source
Active, not recruiting
A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma
NCT02773030· Phase 1/2· Celgene· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error